Ding and coworkers, however, failed to demonstrate a significant effect of the rs1801282 of the PPAR-γ on CAD risk in their meta-analysis (74 studies with 52,998 subjects included) [23]. The gene discussed is PPARG; the disease is coronary artery disorder.